Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jennifer C, Yu"'
Publikováno v:
Case Reports in Hematology, Vol 2024 (2024)
A delayed hemolytic transfusion reaction (DHTR) is a potential complication for patients with sickle cell disease (SCD) who develop red blood cell (RBC) alloimmunization to foreign antigens from allogeneic transfusions, potentially resulting in life-
Externí odkaz:
https://doaj.org/article/33f2af1bd5d24fc8bd30f85143f711b2
Publikováno v:
Clinical Case Reports, Vol 10, Iss 6, Pp n/a-n/a (2022)
Abstract Hemolytic crises and aplastic crises in hereditary spherocytosis (HS) are most commonly triggered by viral infections. We present the case of an adolescent girl with HS who developed unexpected and life‐threatening complications of her inh
Externí odkaz:
https://doaj.org/article/e7fe47dac4d14220b46e4e22a240fcbd
Autor:
Mario Mietzsch, J. Kennon Smith, Jennifer C. Yu, Vibhu Banala, Shanan N. Emmanuel, Ariana Jose, Paul Chipman, Nilakshee Bhattacharya, Robert McKenna, Mavis Agbandje-McKenna
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss , Pp 362-373 (2020)
Affinity-based purification of adeno-associated virus (AAV) vectors has replaced density-based methods for vectors used in clinical settings. This method utilizes camelid single-domain antibodies recognizing AAV capsids. These include AVB Sepharose (
Externí odkaz:
https://doaj.org/article/28d7c2f26301459a88a2ed347f353059
Autor:
Antonette Bennett, Saajan Patel, Mario Mietzsch, Ariana Jose, Bridget Lins-Austin, Jennifer C. Yu, Brian Bothner, Robert McKenna, Mavis Agbandje-McKenna
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 171-182 (2017)
Currently, there are over 150 ongoing clinical trials utilizing adeno-associated viruses (AAVs) to target various genetic diseases, including hemophilia (AAV2 and AAV8), congenital heart failure (AAV1 and AAV6), cystic fibrosis (AAV2), rheumatoid art
Externí odkaz:
https://doaj.org/article/a71fbae096194e05950d838dd37b2f2e
Autor:
Caitlin W. Elgarten, William R. Otto, Luke Shenton, Madison T. Stein, Joseph Horowitz, Catherine Aftandilian, Staci D. Arnold, Kira O. Bona, Emi Caywood, Anderson B. Collier, M. Monica Gramatges, Meret Henry, Craig Lotterman, Kelly Maloney, Arunkumar J. Modi, Amir Mian, Rajen Mody, Elaine Morgan, Elizabeth A. Raetz, Anupam Verma, Naomi Winick, Jennifer J. Wilkes, Jennifer C. Yu, Richard Aplenc, Brian T. Fisher, Kelly D. Getz
Publikováno v:
Infection Control & Hospital Epidemiology. 44:222-229
Background:Bloodstream infections (BSIs) are a frequent cause of morbidity in patients with acute myeloid leukemia (AML), due in part to the presence of central venous access devices (CVADs) required to deliver therapy.Objective:To determine the diff
Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology
Autor:
Mario Mietzsch, Robert McKenna, Elina Väisänen, Jennifer C. Yu, Maria Ilyas, Joshua A. Hull, Justin Kurian, J. Kennon Smith, Paul Chipman, Yi Lasanajak, David Smith, Maria Söderlund-Venermo, Mavis Agbandje-McKenna
Publikováno v:
Viruses, Vol 12, Iss 6, p 653 (2020)
Several members of the Protoparvovirus genus, capable of infecting humans, have been recently discovered, including cutavirus (CuV) and tusavirus (TuV). To begin the characterization of these viruses, we have used cryo-electron microscopy and image r
Externí odkaz:
https://doaj.org/article/e99c377f263140b48244571e8bed3873
Autor:
Jong Chung, Geetha Puthenveetil, Sanjay Shah, Elliott Vichinsky, Aditi Kamdar, Jennifer C. Yu, Trisha E. Wong, Monica B. Pagano, Sioban Keel, Alan Ikeda, Ashutosh Lal, Latha Rao
Publikováno v:
Transfusion. 61:3027-3039
Autor:
Justin J. Kurian, Renuk Lakshmanan, William M. Chmely, Joshua A. Hull, Jennifer C. Yu, Antonette Bennett, Robert McKenna, Mavis Agbandje-McKenna
Publikováno v:
Viruses, Vol 11, Iss 5, p 399 (2019)
Adeno-associated viruses (AAVs) are being developed for gene delivery applications, with more than 100 ongoing clinical trials aimed at the treatment of monogenic diseases. In this study, the unique N-terminus of AAV capsid viral protein 1 (VP1u), co
Externí odkaz:
https://doaj.org/article/b6837595f4834aa7978d20ab215076b9
Autor:
Mario Mietzsch, Joshua A. Hull, Victoria E. Makal, Alberto Jimenez Ybargollin, Jennifer C. Yu, Kedrick McKissock, Antonette Bennett, Judit Penzes, Bridget Lins-Austin, Qian Yu, Paul Chipman, Nilakshee Bhattacharya, Duncan Sousa, David Strugatsky, Peter Tijssen, Robert McKenna, Mavis Agbandje-McKenna
Publikováno v:
J Virol
Adeno-associated viruses (AAVs) are being developed as clinical gene therapy vectors. One issue undermining their broad use in the clinical setting is the high prevalence of circulating antibodies in the general population capable of neutralizing AAV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04a8a862c9fd3f640f341b011cb7cd8
https://europepmc.org/articles/PMC9175632/
https://europepmc.org/articles/PMC9175632/
Autor:
Nilakshee Bhattacharya, Ariana Jose, Jennifer C. Yu, J. Kennon Smith, Shanan N Emmanuel, Mario Mietzsch, Vibhu Banala, Mavis Agbandje-McKenna, Paul R. Chipman, Robert McKenna
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss, Pp 362-373 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Affinity-based purification of adeno-associated virus (AAV) vectors has replaced density-based methods for vectors used in clinical settings. This method utilizes camelid single-domain antibodies recognizing AAV capsids. These include AVB Sepharose (